Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER).
Saved in:
| Title: | Evaluation of the oral human abuse potential of Oxycodone DETERx® formulation (Xtampza® ER). |
|---|---|
| Authors: | Meske D; Manager, Clinical Development & Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Kopecky EA; Vice President, Clinical Development; Head, Neuroscience, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Passik S; Vice President, Scientific Affairs, Collegium Pharmaceutical, Inc., Canton, Massachusetts., Shram MJ; Director, Altreos Research Partners, Inc., Toronto, Ontario, Canada. |
| Source: | Journal of opioid management [J Opioid Manag] 2018 Sep/Oct; Vol. 14 (5), pp. 359-372. |
| Publication Type: | Comparative Study; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Weston Medical Pub Country of Publication: United States NLM ID: 101234523 Publication Model: Print Cited Medium: Print ISSN: 1551-7489 (Print) Linking ISSN: 15517489 NLM ISO Abbreviation: J Opioid Manag Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
